In this issue:
Safety and efficacy of parsaclisib
Efficacy of KRd therapy
Axi-cel plus utomilumab in LBCL patients
Updated pooled analysis of zanubrutinib
Use of dasatinib in CML patients in chronic phase
Comparing older and younger AML characteristics
Mosunetuzumab plus CHOP
Tolerability of venetoclax and discontinuation of azacitinib
Combined therapy of glasdegib and chemotherapy
Efficacy of romidepsin plus lenalidomide
Please login below to download this issue (PDF)